October 15, 2013
Dr. Igor Efimov is the Lucy and Stanley Lopata Distinguished Professor of Biomedical Engineering, and Professor of Cell Biology and Physiology, Medicine (Cardiology), and Radiology at Washington University. He is also the Primary Investigator at the Cardiac Imaging Laboratory, an NIH-funded research laboratory that studies the biophysical mechanisms of cardiac conduction and arrhythmia. He has developed novel anti-arrhythmia therapies, including low-energy defibrillation therapy. In 2008, Dr. Efimov co-founded Cardialen, Inc. to develop pain-free cardioversion therapy, with a primary focus on atrial fibrillation. In 2012, he co-founded PharusCardio, which aims to develop novel invasive and non-invasive cardiac imaging modalities.
Dr. Efimov obtained his PhD from Moscow Institute of Physics and Technology in 1992, and completed his postdoctoral training at the University of Pittsburgh (1992 to 1994).
Dr. Efimov has been a member on the Program Committee History Committee of the Heart Rhythm Society since 2009. He is a Fellow of the Heart Rhythm Society and the American Heart Association. He is Associate Editor of the American Journal of Physiology: Heart and Circulatory Physiology. He is also a chartered member of the National Institutes of Health Electrical Signaling, Transporters and Arrhythmia Study Section and NHLBI Systems Biology Collaborations review group.